Why is the market valuing Decibel at less than 2× our projected 2027 EBITDA?

We sat down with Benjamin Sze, CEO of Decibel Cannabis Company, following the company's latest quarterly results.

In this 11-minute conversation, we discuss:

  • Q2 revenue and EBITDA
  • Domestic growth and market-share gains
  • International expansion • EU-GMP processing
  • 50 cultivator customers and 16 overseas distributors
  • Free cash flow generation
  • Raised 2026 guidance
  • The company's strategic value in a consolidating industry

Our latest report rates Decibel Overweight.

Our CY27 estimates imply 0.5× sales and 1.8× EBITDA.

And while Zuanic & Associates does not publish price targets, our analysis shows that applying a 10× EBITDA multiple to our projected 2027 EBITDA would imply greater than 5× upside by December 2026.

Read the full research report and watch the CEO interview for the complete thesis, assumptions and risks.

#Decibel #DecibelCannabis #DB #DBCCF #TSXV #OTCQB #Stocks #Investing #EquityResearch #SmallCapStocks #CanadianStocks #GrowthStocks #MarketAnalysis

Podden och tillhörande omslagsbild på den här sidan tillhör Pablo Zuanic. Innehållet i podden är skapat av Pablo Zuanic och inte av, eller tillsammans med, Poddtoppen.